New Delhi, India: Fortis Healthcare announced a strong financial performance for the quarter ended March 31st, 2026. The results were aided by a sustained increase in its core hospitals, an increasing number of patients across specialties, strategic network expansions through acquisitions, and brownfield projects.

The healthcare company reported consolidated revenues of Rs2,365 billion in Q4 FY26. This represents a 17.8% increase compared to the Rs2,007 billion in the same quarter last year. Operating EBITDA increased by 22.2% to Rs531 billion, and margins rose to 22.5% from 21.7% a year earlier.

The profit after tax in the Q4 of FY25 grew by 44.2%, to Rs271 cr. The company’s total revenues for the year FY26 grew by 17.3 percent to Rs9 128 crore, compared to the Rs7 783 crore reported in FY25. Operating EBITDA grew by 31.3% to Rs 2,085 crore. Margins increased to 22.8% from 20.4% in the previous fiscal.

The company’s annual profit was Rs 1,064 billion, up 31.5% year-onyear.

In addition, the board of directors recommended a dividend per equity share of Rs1, which is equivalent to 10% of its face value.

Hospital business continued to be the main growth driver, contributing almost 85 percent to total revenues. Hospital revenues increased 19% year-on-year to Rs 2,023 crore in Q4 FY26, and annual hospital revenues increased 19.1% to Rs 7,773 crore.

The company saw a 15% increase in the number of occupied beds over the course of FY26, and a 17% rise during the 4th quarter when compared with the same period last year. The Average Revenue per Occupied bed (ARPOB), a measure of revenue generated by occupied beds, rose to Rs2.56 crores annually in Q4 Q4 FY26 compared to Rs2.51 in Q4 Q4 FY25.

The top six specialties of cardiac sciences, orthopedics and neurology, gastroenterology and oncology and renal sciences have grown 18.9% over FY25, contributing nearly 62% to the total revenue. The orthopedics and renal sciences sectors grew by 22 and 21 percent respectively.

The firm also reported a sharp increase in high-end procedures. Radiation thery volumes increased 19% and robotic surgeries grew 66 percent year-over-year during the FY26.

Hospital revenues were 7.8% higher due to an increase of 18.5% in international patient revenues. The company invested in high-value equipment to strengthen its clinical infrastructure. This included five soft tissue surgical robotics, two MRIs, four cath laboratories, and a PET-CT system. Ashutosh Raghuvanshi MD, CEO of Fortis Healthcare commented on the results, saying, “We’ve seen a steady performance in Q4 which has enabled us to finish the year on a positive note.” Our hospital business, which contributes 85% of our total revenues, continues to perform well.

According to Raghuvanshi, the company has maintained its momentum for investing in medical equipment, technologies, and clinical programs, while also pursuing network growth. Agilus Diagnostics’ diagnostics division also showed steady growth. In Q4 FY26 the gross revenues of the diagnostics arm grew by 11.1 percent year-onyear to Rs387.8 crore. Annual revenues grew by 8.5 percent to Rs1,527.8 crore.

The operating EBITDA of the diagnostics division grew by 35.9 percent during the quarter, and 44.7% for the entire year. EBITDA margins grew significantly, reaching 22 per cent during Q4 FY26.

Agilus carried out nearly 40.8million tests in FY26 as compared to 39.2million tests in FY25. By March 31, 2026, the company had expanded its customer touch points to 4,445.

The preventive healthcare sector continued to grow, with revenues for preventive tests increasing by 21 percent during the past year. Their contribution to diagnostics revenues increased from 11 to 13 percent. Fortis’s net debt at the end of March 2026 was Rs 2,334 billion, with a debt-to-EBITDA ratio at 1.09x as compared to 0.93x last year. The company attributes the rise in debt to the acquisitions and expansions undertaken by the company during the past year. Along with business growth, the healthcare group highlighted progress in environmental, social, and governance (ESG), including energy optimization, carbon emissions reduction, water conservancy, and reduced waste generation.

Published on May 23, 2026, at 1:56 PM (IST)

Join our community of over 2 million industry professionals. Subscribe to our Newsletter for the latest industry insights and analysis.

Your smartphone is your portal to ETHealthworld!